SAN DIEGO, Nov. 8, 2011 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's pharmaceutical innovations, today announced a strategic partnership with the Shenzhen Polytechnic School of Applied Chemistry and Biotechnology (SPSACBT). The alliance with HUYA will assist the school in accelerating the development of novel drugs, discovered from research laboratories within the school, to international standards.
The agreement provides HUYA with access to and first review of certain novel therapeutic candidates owned or controlled by SPSACBT. Correspondingly, the school gains access to HUYA's expertise in drug development as well as its global network of pharmaceutical partners.
HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutions throughout China and has pioneered in-licensing innovative compounds from the country, utilizing its expertise to advance these compounds for global markets.
Shenzhen Polytechnic School of Applied Chemistry and Biotechnology is part of Shenzhen Polytechnic located in Shenzhen. The school has a strong research focus with distinguished professors and scientists. In the recent years, it has undertaken three major projects funded by the National Natural Science Foundation and greater than 80 research projects funded by provincial and local government. It has established long-term collaborations with several overseas universities, as well as enterprises and companies in related industries.
"Shenzhen Polytechnic School of Applied Chemistry and Biotechnology is recognized for its strong research capabilities," said Clement Gingras
|SOURCE HUYA Bioscience International|
Copyright©2010 PR Newswire.
All rights reserved